Two decades of gastrointestinal stromal tumor management with first-line treatment: A case report

Last Updated: Friday, July 17, 2026

In this case study, a man in his forties with a jejunal GIST was treated with imatinib. After initial surgery and recurrence, he received imatinib therapy, stopped, and restarted due to further recurrence. He has been on imatinib with good tolerance until March 2024, highlighting the drug's long-term potential.

Cureus

medRxiv

Prediction of mutations and outcome in gastrointestinal stromal tumors with deep learning: A multicenter, multinational study

Clinical & Translational Oncology

Role of cytoreductive surgery in the management of peritoneal metastases for gastrointestinal stromal tumors

Journal of Surgical Case Reports

Incidental finding of gastrointestinal stromal tumor in appendix

World Journal of Gastrointestinal Oncology

Endoscopic vs laparoscopic resection for gastric gastrointestinal stromal tumors: Oncological outcomes

NPJ Precision Oncology

KIT mutation-NTRK fusion oncogenic driver switch: A novel mechanism of acquired imatinib resistance in GIST

Case Reports in Oncological Medicine

Pelvic gastrointestinal stromal tumor (GIST) mimicking ovarian cancer in a kidney-liver transplant recipient under chronic immunosuppression

Updates in Surgery

Laparoscopic resection for gastric gastrointestinal stromal tumor at the esophagogastric junction: Feasibility and long-term results

Life

Nationwide multicenter study of advanced endoscopic resection and malignant risk model for gastric myogenic tumors (GASTRO Trial)

Digestive Endoscopy

Endoscopic diagnosis of gastric subepithelial lesions < 20 mm: Current strategies and emerging solutions

Experimental Oncology

Diagnosis and surgical treatment of gastrointestinal stromal tumors of the stomach using minimally invasive technologies

Gastrointestinal Stromal Tumor Resource Center